Be The Match: How you can donate plasma, stem cells to help cancer patients April 28, 2022 Read More »
FDA Approves Direct Biologics to Proceed with a Landmark Phase 3 Acute Respiratory Distress Syndrome (ARDS) Trial April 27, 2022 Read More »
NexImmune Announces Preclinical Research Collaboration with Columbia University Irving Medical Center’s Herbert Irving Comprehensive Cancer Center April 26, 2022 Read More »
Creative Medical Technology Announces Progress in Developing a Reproducible Clinical Grade of the Company’s ImmCelz® Product April 20, 2022 Read More »
BioRestorative Therapies Announces Selection of 10 Clinical Sites for its Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease April 18, 2022 Read More »
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients April 13, 2022 Read More »
